Stellenbosch University clinical trials unit for HIV and TB
Stellenbosch University Clinical Trials Unit
This Cape Town program runs clinical research to test better HIV and TB prevention and treatment options for children, adolescents, and adults.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stellenbosch University NIH-funded |
| Lab location | 1 site (Stellenbosch, SOUTH AFRICA) |
| Project ID | NIH-11233253 on NIH RePORTER |
What this research studies
From a patient's perspective, the SUN-CTU brings together three local research sites in Cape Town to run studies that could improve prevention, diagnosis, and treatment of HIV and TB across all ages. The unit conducts pharmacokinetics and safety studies of new antiretrovirals, examines drug interactions with TB treatments, and follows early-treated children and adolescents to study remission and neurodevelopment. It also studies adult co-infections such as hepatitis and CMV and participates in international networks like IMPAACT, ACTG, HPTN, and HVTN. Most work is done at local clinics and hospitals where patients receive care and can be asked to join studies or provide samples.
Who could benefit from this research
Good fit: Ideal candidates are people living with or at high risk for HIV or TB—including children, adolescents, and adults—who can attend clinical sites in the Cape Town region.
Not a fit: People without HIV or TB or those unable to travel to the Cape Town sites are unlikely to receive direct benefit from this unit's studies.
Why it matters
Potential benefit: If successful, this work could lead to safer, more effective HIV and TB treatments and better prevention strategies for people of all ages.
How similar studies have performed: Related international network trials (IMPAACT, ACTG, HPTN, HVTN) have produced important HIV and TB advances, so this builds on proven clinical research approaches.
Where this research is happening
Stellenbosch, SOUTH AFRICA
- Stellenbosch University — Stellenbosch, South Africa (Active)
Researchers
- Principal investigator: Hesseling, Anneke Catharina — Stellenbosch University
- Study coordinator: Hesseling, Anneke Catharina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.